After securing a multibillion-dollar biobucks deal with AstraZeneca and raising nearly $100 million last year, peptide drug discovery company Syneron…

In a compelling leap forward for oncology, recent findings from a Phase I dose-expansion study illuminate the promising utility of…

In an era where global populations are aging rapidly, understanding how to maintain quality of life in the elderly has…

In an era where infant nutrition holds paramount importance for the foundational health and development of the next generation, recent…

The landscape of HIV prevention has witnessed a transformative journey over the past decades, with the advent of novel interventions…

In recent years, the global conversation about plastic has shifted dramatically. Once lauded for its durability and versatility, plastic now…

In the rapidly evolving landscape of biomedical engineering, the pursuit to manage chronic diseases through innovative means has spurred tremendous…

The number of drugs in development has fallen for the first time since the mid-1990s, according to a Citeline report.…

In the evolving landscape of geriatric medicine, the treatment of subclinical hypothyroidism (SCH) in older adults has remained a topic…

In a groundbreaking advancement that bridges atmospheric science and sustainable development, a team of researchers has unveiled a comprehensive national-scale…